CTI BioPharma
Founded in 1991, CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. CTI BioPharma has a commercial presence in Europe. CTI BioPharma is headquartered in Seattle, Washington.
Last updated on
About CTI BioPharma
Founded
1992Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$165MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541Location
City
SeattleState
WashingtonCountry
United StatesTech Stack (110)
